Development of a PROTAC Targeting Chk1
S. R. Chowdhury, P. Chuong, V. E. Mgbemena, A. V. Statsyuk
This paper designs and synthesizes Chk1 degraders using a promiscuous kinase binder and thalidomide, showing concentration-dependent reduction of Chk1 in A375 cells.
bioRxiv · Dec 30, 2023 · PreprintCell Biology